Gerald Zernig, Prof Dr, is affiliated with the Department of Pharmacology at the Medical University of Innsbruck and maintains a private practice for psychotherapy in Hall in Tirol, Austria. He is a member of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) Task Force on Therapeutic Drug Monitoring. His publications from 2006 to 2023 focus on psychopharmacology, patient care, and schizophrenia/schizoaffective disorders, including studies on antipsychotic blood levels, pharmacokinetics of antidepressants, and the effects of St. John's Wort during breastfeeding.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
